Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation

Xenotransplantation

Volumn 15, Issue 4, 2008, Pages 268-276

  Byrne, Guerard W ^a   Stalboerger, Paul G ^a   Davila, Eduardo ^a   Heppelmann, Carrie J ^a   Gazi, Mozammel H ^a   McGregor, Hugh C J ^a   LaBreche, Peter T ^a   Davies, William R ^a   Rao, Vinay P ^a   Oi, Keiji ^a   Tazelaar, Henry D ^a   Logan, John S ^a   McGregor, Christopher G A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Endothelial cell; Non Gal antibody; Proteomics; Xenotransplantation

Indexed keywords

GALACTOSYLGALACTOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT REJECTION; HEART GRAFT; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; T LYMPHOCYTE; WESTERN BLOTTING; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES, HETEROPHILE; ANTIBODY SPECIFICITY; DISACCHARIDES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; PAPIO ANUBIS; PROTEOMICS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 50949088377     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2008.00480.x     Document Type: Article

References (38)

1. Leventhal JR, Sakiyalak P, Witson J et al. The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. Transplantation 1993 57 : 974 978.
2. Lin SS, Kooyman DL, Daniels LJ et al. The role of natural anti-Gal-alpha-1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transplant Immunol 1997 5 : 212 218.
3. Logan JS. Prospects for xenotransplantation. Curr Opin Immunol 2000 12 : 563 568.
4. Dorling A. Are anti-endothelial cell antibodies a pre-requisite for the acute vascular rejection of xenografts? Xenotransplantation 2003 10 : 16 23.
5. Mcgregor CGA, Teotia SS, Byrne GW et al. Cardiac xenotransplantation: progress toward the clinic. Transplantation 2004 78 : 1569 1575.
6. Byrne GW, Schwarz A, Fesi JR et al. Evaluation of different alpha-galactosyl glycoconjugates for use in xenotransplantation. Bioconjug Chem 2002 13 : 571 581.
7. Diamond LE, Byrne GW, Schwarz A et al. Analysis of the control of the anti-Gal immune response in a non-human primate by galactose alpha-1-3 galactose trisaccharide-polyethylene glycol conjugate. Transplantation 2002 73 : 1780 1787.
8. Katopodis AG, Warner RG, Duthaler RO et al. Removal of anti-Galα1,3Gal xenoantibodies with an injectable polymer. J Clin Invest 2002 110 : 1869 1877.
9. Lam TT, Paniagua R, Shivaram G et al. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys. Xenotransplantation 2004 11 : 531 535.
10. Mcgregor CGA, Davies WR, OI K et al. Cardiac xenotransplantation: recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 2005 130 : 844 851.
11. Byrne GW, Schirmer JM, Fass DN et al. Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. Am J Transplant 2005 5 : 1011 1020.
12. Kuwaki K, Tseng YL, Dor FJ et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005 11 : 29 31.
13. Chen G, Qian H, Starzl T et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005 : 11 : 1295 1298 Epub November 2005, 1227 G, Sun H, Yang H et al. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation 2006 81 : 273 283.
14. Kopp CW, Siegel JB, Hancock WW et al. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation 1997 63 : 749 758.
15. Siegel JB, Grey ST, Lesnikoski BA et al. Xenogeneic endothelial cells activate human prothrombin. Transplantation 1997 64 : 888 896.
16. Mazzucato M, Demarco L, Pradella P et al. Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx. Thromb Haemost 1996 75 : 655 660.
17. Cozzi E, Simioni P, Boldrin M et al. Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts. Transplantation 2005 80 : 1501 1510.
18. Schirmer JM, Fass DN, Byrne GW et al. Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival. Xenotransplantation 2004 11 : 436 443.
19. Buhler L, XU Y, LI W et al. An investigation of the specificity of induced anti-pig antibodies in baboons. Xenotransplantation 2003 10 : 88 93.
20. Tseng YL, Moran K, Dor FJ et al. Elicited antibodies in baboons exposed to tissues from alpha1,3-galactosyltransferase gene-knockout pigs. Transplantation 2006 81 : 1058 1062.
21. Mccurry KR, Kooyman DL, Alvarado CG et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995 1 : 423 427.
22. Sharma A, Naziruddin B, Cui C et al. Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen. Transplantation 2003 75 : 430 436.
23. Davila E, Byrne GW, Labreche PT et al. T-cell responses during pig-to-primate xenotransplantation. Xenotransplantation 2006 13 : 31 40.
24. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002 74 : 5383 5392.
25. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003 75 : 4646 4658.
26. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007 7 : 610 621.
27. Yates SF, Paterson AM, Nolan KF et al. Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J Immunol 2007 179 : 967 976.
28. Sela M, Mozes E. Therapeutic vaccines in autoimmunity. Proc Natl Acad Sci USA 2004 101 (Suppl. 2 14586 14592.
29. Ierino FL, Gojo S, Banerjee PT et al. Transfer of swine major histocompatibility complex class II genes into autologuous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers. Transplantation 1999 67 : 1119 1128.
30. Bracy JL, Iacomini J. Induction of B-cell tolerance by retroviral gene therapy. Blood 2000 96 : 3008 3015.
31. Borozdenkova S, Westbrook JA, Patel V et al. Use of proteomics to discover novel markers of cardiac allograft rejection. J Proteome Res 2004 3 : 282 288.
32. Caron M, Choquet-Kastylevsky G, Joubert-Caron R. Cancer immunomics using autoantibody signatures for biomarker discovery. Mol Cell Proteomics 2007 6 : 1115 1122.
33. Latif N, Baker CS, Dunn MJ et al. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol 1993 22 : 1378 1384.
34. Parker W, Bruno D, Holzknecht ZE, Platt JL. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol 1994 153 : 3791 3803.
35. Foteinos G, Afzal AR, Mandal K et al. Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage. Circulation 2005 112 : 1206 1213.
36. Pockley AG, Muthana M. Heat shock proteins and allograft rejection. Contrib Nephrol 2005 148 : 122 134.
37. Rescher U, Gerke V. Annexins - unique membrane binding proteins with diverse functions. J Cell Sci 2004 117 : 2631 2639.
38. Santoni V, Molloy M, Rabilloud T. Membrane proteins and proteomics: un amour impossible? Electrophoresis 2000 21 : 1054 1070.